Cargando…

Inter- and intra-reader agreement for gadoxetic acid–enhanced MRI parameter readings in patients with chronic liver diseases

OBJECTIVES: To examine inter- and intra-observer agreement for four simple hepatobiliary phase (HBP)–based scores on gadoxetic acid (GA)–enhanced MRI and their correlation with liver function in patients with mixed chronic liver disease (CLD). METHODS: This single-center, retrospective study include...

Descripción completa

Detalles Bibliográficos
Autores principales: Beer, Lucian, Mandorfer, Mattias, Bastati, Nina, Poetter-Lang, Sarah, Tamandl, Dietmar, Stoyanova, Dilyana Plamenova, Elmer, Michael Christoph, Semmler, Georg, Simbrunner, Benedikt, Hodge, Jacqueline C., Sirlin, Claude B., Reiberger, Thomas, Ba-Ssalamah, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828941/
https://www.ncbi.nlm.nih.gov/pubmed/31001679
http://dx.doi.org/10.1007/s00330-019-06182-z
_version_ 1783465452795592704
author Beer, Lucian
Mandorfer, Mattias
Bastati, Nina
Poetter-Lang, Sarah
Tamandl, Dietmar
Stoyanova, Dilyana Plamenova
Elmer, Michael Christoph
Semmler, Georg
Simbrunner, Benedikt
Hodge, Jacqueline C.
Sirlin, Claude B.
Reiberger, Thomas
Ba-Ssalamah, Ahmed
author_facet Beer, Lucian
Mandorfer, Mattias
Bastati, Nina
Poetter-Lang, Sarah
Tamandl, Dietmar
Stoyanova, Dilyana Plamenova
Elmer, Michael Christoph
Semmler, Georg
Simbrunner, Benedikt
Hodge, Jacqueline C.
Sirlin, Claude B.
Reiberger, Thomas
Ba-Ssalamah, Ahmed
author_sort Beer, Lucian
collection PubMed
description OBJECTIVES: To examine inter- and intra-observer agreement for four simple hepatobiliary phase (HBP)–based scores on gadoxetic acid (GA)–enhanced MRI and their correlation with liver function in patients with mixed chronic liver disease (CLD). METHODS: This single-center, retrospective study included 287 patients (62% male, 38% female, mean age 53.5 ± 13.7 years) with mixed CLD (20.9% hepatitis C, 19.2% alcoholic liver disease, 8% hepatitis B) who underwent GA-enhanced MRI of the liver for clinical care between 2010 and 2015. Relative liver enhancement (RLE), contrast uptake index (CUI), hepatic uptake index (HUI), and liver-to-spleen contrast index (LSI) were calculated by two radiologists independently using unenhanced and GA-enhanced HPB (obtained 20 min after GA administration) images; 50 patients selected at random were reviewed twice by one reader to assess intra-observer reliability. Agreement was assessed by intraclass correlation coefficient (ICC). The albumin-bilirubin (ALBI) score, the model of end-stage liver disease (MELD), and the Child-Turcotte-Pugh (CTP) score were calculated as standards of reference for hepatic function. RESULTS: Intra-observer ICCs ranged from 0.814 (0.668–0.896) for CUI to 0.969 (0.945–0.983) for RLE. Inter-observer ICCs ranged from 0.777 (0.605–0.874) for HUI to 0.979 (0.963–0.988) for RLE. All HBP-based scores correlated significantly (all p < 0.001) with the ALBI, MELD, and CTP scores and were able to discriminate patients with a MELD score ≥ 15 versus ≤ 14, with area under the curve values ranging from 0.760 for RLE to 0.782 for HUI. CONCLUSION: GA-enhanced, MRI-derived, HBP-based parameters showed excellent inter- and intra-observer agreement. All HBP-based parameters correlated with clinical and laboratory scores of hepatic dysfunction, with no significant differences between each other. KEY POINTS: • Radiological parameters that quantify the hepatic uptake of gadoxetic acid are highly reproducible. • These parameters can be used interchangeably because they correlate with each other and with scores of hepatic dysfunction. • Assessment of these parameters may be helpful in monitoring disease progression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00330-019-06182-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6828941
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-68289412019-11-18 Inter- and intra-reader agreement for gadoxetic acid–enhanced MRI parameter readings in patients with chronic liver diseases Beer, Lucian Mandorfer, Mattias Bastati, Nina Poetter-Lang, Sarah Tamandl, Dietmar Stoyanova, Dilyana Plamenova Elmer, Michael Christoph Semmler, Georg Simbrunner, Benedikt Hodge, Jacqueline C. Sirlin, Claude B. Reiberger, Thomas Ba-Ssalamah, Ahmed Eur Radiol Magnetic Resonance OBJECTIVES: To examine inter- and intra-observer agreement for four simple hepatobiliary phase (HBP)–based scores on gadoxetic acid (GA)–enhanced MRI and their correlation with liver function in patients with mixed chronic liver disease (CLD). METHODS: This single-center, retrospective study included 287 patients (62% male, 38% female, mean age 53.5 ± 13.7 years) with mixed CLD (20.9% hepatitis C, 19.2% alcoholic liver disease, 8% hepatitis B) who underwent GA-enhanced MRI of the liver for clinical care between 2010 and 2015. Relative liver enhancement (RLE), contrast uptake index (CUI), hepatic uptake index (HUI), and liver-to-spleen contrast index (LSI) were calculated by two radiologists independently using unenhanced and GA-enhanced HPB (obtained 20 min after GA administration) images; 50 patients selected at random were reviewed twice by one reader to assess intra-observer reliability. Agreement was assessed by intraclass correlation coefficient (ICC). The albumin-bilirubin (ALBI) score, the model of end-stage liver disease (MELD), and the Child-Turcotte-Pugh (CTP) score were calculated as standards of reference for hepatic function. RESULTS: Intra-observer ICCs ranged from 0.814 (0.668–0.896) for CUI to 0.969 (0.945–0.983) for RLE. Inter-observer ICCs ranged from 0.777 (0.605–0.874) for HUI to 0.979 (0.963–0.988) for RLE. All HBP-based scores correlated significantly (all p < 0.001) with the ALBI, MELD, and CTP scores and were able to discriminate patients with a MELD score ≥ 15 versus ≤ 14, with area under the curve values ranging from 0.760 for RLE to 0.782 for HUI. CONCLUSION: GA-enhanced, MRI-derived, HBP-based parameters showed excellent inter- and intra-observer agreement. All HBP-based parameters correlated with clinical and laboratory scores of hepatic dysfunction, with no significant differences between each other. KEY POINTS: • Radiological parameters that quantify the hepatic uptake of gadoxetic acid are highly reproducible. • These parameters can be used interchangeably because they correlate with each other and with scores of hepatic dysfunction. • Assessment of these parameters may be helpful in monitoring disease progression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00330-019-06182-z) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2019-04-18 2019 /pmc/articles/PMC6828941/ /pubmed/31001679 http://dx.doi.org/10.1007/s00330-019-06182-z Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Magnetic Resonance
Beer, Lucian
Mandorfer, Mattias
Bastati, Nina
Poetter-Lang, Sarah
Tamandl, Dietmar
Stoyanova, Dilyana Plamenova
Elmer, Michael Christoph
Semmler, Georg
Simbrunner, Benedikt
Hodge, Jacqueline C.
Sirlin, Claude B.
Reiberger, Thomas
Ba-Ssalamah, Ahmed
Inter- and intra-reader agreement for gadoxetic acid–enhanced MRI parameter readings in patients with chronic liver diseases
title Inter- and intra-reader agreement for gadoxetic acid–enhanced MRI parameter readings in patients with chronic liver diseases
title_full Inter- and intra-reader agreement for gadoxetic acid–enhanced MRI parameter readings in patients with chronic liver diseases
title_fullStr Inter- and intra-reader agreement for gadoxetic acid–enhanced MRI parameter readings in patients with chronic liver diseases
title_full_unstemmed Inter- and intra-reader agreement for gadoxetic acid–enhanced MRI parameter readings in patients with chronic liver diseases
title_short Inter- and intra-reader agreement for gadoxetic acid–enhanced MRI parameter readings in patients with chronic liver diseases
title_sort inter- and intra-reader agreement for gadoxetic acid–enhanced mri parameter readings in patients with chronic liver diseases
topic Magnetic Resonance
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828941/
https://www.ncbi.nlm.nih.gov/pubmed/31001679
http://dx.doi.org/10.1007/s00330-019-06182-z
work_keys_str_mv AT beerlucian interandintrareaderagreementforgadoxeticacidenhancedmriparameterreadingsinpatientswithchronicliverdiseases
AT mandorfermattias interandintrareaderagreementforgadoxeticacidenhancedmriparameterreadingsinpatientswithchronicliverdiseases
AT bastatinina interandintrareaderagreementforgadoxeticacidenhancedmriparameterreadingsinpatientswithchronicliverdiseases
AT poetterlangsarah interandintrareaderagreementforgadoxeticacidenhancedmriparameterreadingsinpatientswithchronicliverdiseases
AT tamandldietmar interandintrareaderagreementforgadoxeticacidenhancedmriparameterreadingsinpatientswithchronicliverdiseases
AT stoyanovadilyanaplamenova interandintrareaderagreementforgadoxeticacidenhancedmriparameterreadingsinpatientswithchronicliverdiseases
AT elmermichaelchristoph interandintrareaderagreementforgadoxeticacidenhancedmriparameterreadingsinpatientswithchronicliverdiseases
AT semmlergeorg interandintrareaderagreementforgadoxeticacidenhancedmriparameterreadingsinpatientswithchronicliverdiseases
AT simbrunnerbenedikt interandintrareaderagreementforgadoxeticacidenhancedmriparameterreadingsinpatientswithchronicliverdiseases
AT hodgejacquelinec interandintrareaderagreementforgadoxeticacidenhancedmriparameterreadingsinpatientswithchronicliverdiseases
AT sirlinclaudeb interandintrareaderagreementforgadoxeticacidenhancedmriparameterreadingsinpatientswithchronicliverdiseases
AT reibergerthomas interandintrareaderagreementforgadoxeticacidenhancedmriparameterreadingsinpatientswithchronicliverdiseases
AT bassalamahahmed interandintrareaderagreementforgadoxeticacidenhancedmriparameterreadingsinpatientswithchronicliverdiseases